Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Effects of prebiotics on gut health in ulcerative colitis

Official title: The Clinical and Microbial Impact of Prebiotics in Ulcerative Colitis

Run by University of California, Los Angeles · NCT06495658 · Data updated 2026-11-12

This study is testing if taking prebiotics can improve gut health in people with ulcerative colitis who have active symptoms.

More Ulcerative Colitis trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment70 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedJuly 9, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedFebruary 27, 2026
Trial IDNCT06495658 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 85 with a history of biopsy-proven ulcerative colitis and active symptoms.

Probably not a fit

Patients who have undergone prior colectomy or have unstable major medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of prebiotic supplementation on gut microbiome composition and overall gut health in patients with ulcerative colitis. Participants aged 18 to 85 with active symptoms will be randomized to receive prebiotics for either 8 weeks starting at week 0 or week 8. Dietary composition will be assessed at baseline and throughout the 16-week period, with stool samples collected for analysis of microbial changes. The goal is to understand how dietary interventions can influence IBD outcomes.

Why it matters

Potential benefit: If successful, this study could provide new dietary strategies to improve gut health and manage symptoms in patients with ulcerative colitis.

How similar studies have gone: Previous studies have indicated that dietary interventions can positively affect gut microbiome composition, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 18 to 85 years old
* History of biopsy-proven ulcerative colitis (UC)
* Active symptoms (SCCAI \>2)
* Concomitant use of 5-aminosalicylates, immunomodulators, and corticosteroids will be permitted, although initiation or dose adjustment must not have occurred within 30 days prior to enrollment.
* Concomitant use of biologic therapy will be permitted, although initiation or dose adjustment must not have occurred within 60 days prior to enrollment.
* Prior probiotics or other dietary supplements use is permitted but will be asked to be discontinued during the course of the trial

Exclusion Criteria:

* Prior colectomy
* Hospitalization
* Urgent need for abdominal surgery
* Unstable major medical condition
* Active malignancy under treatment
* Active alcohol or non-cannabinoid substance abuse
* Pregnancy or lactation
* Concerns for non-compliance

Where it's running

  • UCLA
    Los Angeles, California, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.